Increased DMT1 but not IREG1 or HFE mRNA following iron depletion therapy in hereditary haemochromatosis

Kelleher, T.; Ryan, E.; Barrett, S.; Sweeney, M.; Byrnes, V.; O'Keane, C.; Crowe, J.
August 2004
Gut;Aug2004, Vol. 53 Issue 8, p1174
Academic Journal
Background and aims: While upregulation of divalent metal transporter 1 (DMT1) and iron regulated gene 1 (IREG1) within duodenal enterocytes is reported in patients with hereditary haemochromatosis (HH), these findings are controversial. Furthermore, the effect of HFE, the gene mutated in HH, on expression of these molecules is unclear. This study examines duodenal expression of these three molecules in HH patients (prior to and following phlebotomy), in patients with iron deficiency (ID), and in controls. Methods: DM11, IREG1, and HFE mRNA were measured in duodenal tissue of C282Y homozygous HH patients, in ID patients negative for the C282Y mutation with a serum ferritin concentration less than 20 jig/I, and in controls negative for C282Y and H63D mutations with normal iron indices, using real time polymerase chain reaction. Results: DMT1 and IREG1 mRNA levels were not significantly different in non-phlebotomised (untreated) HH patients compared with controls. DMT1 expression was significantly increased in HH patients who had undergone phlebotomy therapy (treated) and in patients with ID compared with controls. IREG1 was significantly increased in ID patients relative to controls, and while IREG1 expression was 1 .8-fold greater in treated HH patients, this was not statistically significant. HFE mRNA expression was not significantly different in any of the groups investigated relative to controls. Conclusions: These findings demonstrate that untreated HH patients do not have increased duodenal DMT1 and IREG mRNA, but rather phlebotomy increases expression of these molecules, reflecting the effect of phlebotomy induced erythropoiesis. Finally, HFE appears to play a minor role in the regulation of iron absorption by the duodenal enterocyte.


Related Articles

  • Recent advances in hereditary hemochromatosis. Franchini, Massimo; Veneri, Dino // Annals of Hematology;Jun2005, Vol. 84 Issue 6, p347 

    Hereditary hemochromatosis, a very common genetic defect in the Caucasian population, is characterized by progressive tissue iron overload which leads to irreversible organ damage if it is not treated in a timely manner. Recent developments in the field of molecular medicine have radically...

  • Sex, Drugs, and "Heavy Metal": Does Diet Also Matter in the Clinical Expression of Hereditary Hemochromatosis? McCune, C. Anne // Mayo Clinic Proceedings;May2008, Vol. 83 Issue 5, p526 

    The author reflects on the effect of diet in the clinical expression of hereditary hemochromatosis (HH). She states that most cases of hemochromatosis can be explicated by the defective synthesis or activity of the key iron-regulatory hormone, hepcidin, macrophages and placenta. She added that...

  • Distribution and Quantitation of Skin Iron in Primary Haemochromatosis: Correlation with Total Body Iron Stores in Patients Undergoing Phlebotomy. PINHEIRO, Teresa; SILVA, Raquel; FLEMING, Rita; GONÇALVES, Afonso; BARREIROS, Maria A.; SILVA, João N.; MORLIÈRE, Patrice; SANTUS, René; FILIPE, Paulo // Acta Dermato-Venereologica;2013, Vol. 94 Issue 1, p14 

    Measurement of the concentration of iron in the skin, if correlated with total body iron stores, may enable better informed decisions on when to initiate, change or stop therapy in hereditary heamochromatosis. Naive haemochromatosis patients with iron overload and with C282Y and/or H63D HFE...

  • Heterozygous recipient and donor HFE mutations associated with a hereditary haemochromatosis phenotype after liver transplantation. Wigg, A.J.; Harley, H.; Casey, G. // Gut;Mar2003, Vol. 52 Issue 3, p433 

    We observed the development of phenotypic hereditary haemochromatosis in a non-hereditary haemochromatosis liver transplant recipient, following transplantation with a liver from a C282Y heterozygous donor. No cause for secondary iron overload was identified. Subsequent sequencing of the HFE...

  • Haemochromatosis. Pietrangelo, A. // Gut;May2003 Supplement 2, Vol. 52, pIi23 

    Iron is an important component of the Earth's crust, but its own chemistry greatly limits utilization and also sets the basis for its toxicity. The capacity of readily exchanging electrons in aerobic conditions makes iron essential for fundamental cell functions, such as DNA synthesis, transport...

  • Hepatic Iron Concentration in Hereditary Hemochromatosis Does Not Saturate or Accurately Predict Phlebotomy Requirements. Olynyk, John K.; Luxon, Bruce A.; Britton, Robert S.; Bacon, Bruce R. // American Journal of Gastroenterology;Mar1998, Vol. 93 Issue 3, p346 

    Objective: Biochemical measurement of the hepatic iron concentration (HIC) is essential for the diagnosis of hereditary hemochromatosis (HH). The aim of this study was to determine whether the HIC at the time of diagnosis could predict the subsequent phlebotomy requirements and to determine...

  • Increase in type II collagen turnover after iron depletion in patients with hereditary haemochromatosis. Richette, Pascal; Eymard, Claire; Deberg, Michelle; Vidaud, Dominique; De Kerguenec, Caroline; Valla, Dominique; Vicaut, Eric; Bardin, Thomas; Henrotin, Yves // Rheumatology;Apr2010, Vol. 49 Issue 4, p760 

    Objective. To determine the effects of iron depletion on serum levels of joint biomarkers and on joint symptoms in patients with hereditary haemochromatosis (HH).

  • Raised ferritin.  // Independent Nurse;6/4/2010, p1 

    The article discusses the implications of raised ferritin levels. Low ferritin levels are useful for assessing patients with suspected iron deficiency while high ferritin levels may suggest a disorder that has led to an excess accumulation of iron, resulting in iron overload. Management depends...

  • HYPOGONADAL-INDUCED ANEMIA IN GENETIC HEMOCHROMATOSIS: IMPLICATIONS FOR PHLEBOTOMY THERAPY. Sigal, Samuel H.; Fleischner, Gerald M.; Weiner, Francis R. // American Journal of Gastroenterology;Jan1995, Vol. 90 Issue 1, p152 

    Presents a case of a patient with hypogonadal-induced anemia in genetic hemochromatosis. Results of a pathological iron accumulation in genetic hemochromatosis; Medical evaluation of the patient; Implications of the disease for phlebotomy therapy.


Read the Article


Sign out of this library

Other Topics